lomustine and plx4032

lomustine has been researched along with plx4032 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hernberg, M; Kohtamäki, L; Koivunen, J; Mäkelä, S; Mattila, KE; Ramadan, S; Skyttä, T; Tiainen, L; Tyynelä-Korhonen, K; Vihinen, P; Vuoristo, MS	1

Other Studies

1 other study(ies) available for lomustine and plx4032

Article	Year
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma. Acta oncologica (Stockholm, Sweden), 2020, Volume: 59, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Female; Follow-Up Studies; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Prognosis; Survival Rate; Temozolomide; Vemurafenib; Vincristine	2020

Article

Year

Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma.

Acta oncologica (Stockholm, Sweden), 2020, Volume: 59, Issue:3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Female; Follow-Up Studies; Humans; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Prognosis; Survival Rate; Temozolomide; Vemurafenib; Vincristine

2020